The glioma patients were divided into nine subgroups: astrocytoma, oligodendroglioma, glioma with or without IDH mutation, glioma with IDH mutation with or without co-deletion of 1p and 19q, tumor grade II, III, and IV (Figure 3A). This evidence concerns the gene IDH1 and neoplasm.